Samantha McLemore - Patient Capital Management,
Holding/activity history for Crocs Inc. (CROX)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 842,842 | 2.61 | Add 11.08% | 0.26 | $83.02 | $69,972,795 | SEC |
| 2025 Q4 | 758,797 | 2.50 | Add 28.87% | 0.56 | $85.52 | $64,892,321 | SEC |
| 2025 Q3 | 588,794 | 1.97 | Add 16.97% | 0.29 | $83.55 | $49,193,697 | SEC |
| 2025 Q2 | 503,378 | 2.30 | Reduce 1.57% | 0.04 | $101.28 | $50,982,102 | SEC |
| 2025 Q1 | 511,399 | 2.79 | Add 14.86% | 0.36 | $106.20 | $54,310,622 | SEC |
| 2024 Q4 | 445,227 | 2.25 | Add 16.87% | 0.32 | $109.53 | $48,765,674 | SEC |
| 2024 Q3 | 380,969 | 2.71 | Add 0.38% | 0.01 | $144.81 | $55,168,167 | SEC |
| 2024 Q2 | 379,509 | 2.94 | Reduce 9.44% | 0.28 | $145.94 | $55,385,499 | SEC |
| 2024 Q1 | 419,057 | 2.93 | Reduce 0.70% | 0.01 | $143.80 | $60,260,447 | SEC |
| 2023 Q4 | 422,010 | 2.09 | Buy | 2.09 | $93.41 | $39,419,951 | SEC |